Sponsor

Copenhagen University Hospital at Herlev

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Copenhagen University Hospital at Herlev appears in 32 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials32
Recruiting shown9
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

32 shown
Prevention of Preeclampsia in Denmark: A National Implementation StudyNCT07485140 · lead sponsor · 2025-09-15
RECRUITING
Benefit of Spectral Information in Patients Suspected for Lung CancerNCT06440616 · lead sponsor · 2024-05-24
RECRUITING
High Impact Training to Patients with Prostate Cancer and Bone MetastasesNCT06259279 · lead sponsor · 2024-02-06
RECRUITING
An Explorative Study of Treatment of Contact Dermatitis Due to DiabetesDevicesNCT04909983 · lead sponsor · 2021-05-19
TERMINATED
Prevention of Skin Problems With Diabetes Devices in Pediatric PatientsNCT04258904 · lead sponsor · 2020-03-10
COMPLETED
Meals on Wheels, the Effect of a Home Food-delivery Service for Cancer PatientsNCT02093312 · lead sponsor · 2014-03-01
COMPLETED
Prevalence of Neglected Side Effects to Radical ProstatectomyNCT01742962 · lead sponsor · 2012-12-01
COMPLETED
Mechanical Nerve Stimulation in the Treatment of Post Prostatectomy IncontinenceNCT01540656 · lead sponsor · 2012-06-01
UNKNOWN
Treatment Frequency and Satisfaction in Patients With Advanced Prostate CancerNCT01441713 · lead sponsor · 2011-09-01
COMPLETED
Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish SetupNCT01640262 · lead sponsor · 2011-08-01
COMPLETED
Vitamin C as an Anti-cancer DrugNCT01080352 · lead sponsor · 2010-11-01
COMPLETED
Can Methylprednisoloneacetate Prevent Seroma After Mastectomy for Primary Breast CancerNCT01380912 · lead sponsor · 2010-08-01
UNKNOWN
Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.NCT00744653 · lead sponsor · 2008-10-01
TERMINATED
Diffusion Weighted MRI for Lymphnodes in the AxillaNCT00276211 · lead sponsor · 2006-01-01
COMPLETED
Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging StudyNCT07482072 · collaborator · 2026-03-01
RECRUITING
Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 FractionsNCT07343349 · collaborator · 2025-12-15
RECRUITING
Remote Monitoring of Cardiac Mechanics in Heart Failure PatientsNCT06885164 · collaborator · 2025-06-11
RECRUITING
Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart FailureNCT06653725 · collaborator · 2025-03-20
RECRUITING
The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease.NCT06600412 · collaborator · 2024-10-10
RECRUITING
STRONG for Surgery & Strong for Life - Intensive Prehabilitation for Risk Reduction in Ventral Hernia RepairNCT06611462 · collaborator · 2024-03-04
RECRUITING
Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung CancerNCT07432802 · collaborator · 2026-09-01
NOT_YET_RECRUITING
Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in RadiotherapyNCT07185958 · collaborator · 2025-09-22
NOT_YET_RECRUITING
Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPDNCT06636487 · collaborator · 2024-11-01
ACTIVE_NOT_RECRUITING
Isotonic Saline for Children With BronchiolitisNCT05902702 · collaborator · 2023-09-01
NOT_YET_RECRUITING
Maxillary Sinus Floor Augmentation in Diabetic PatientsNCT04543630 · collaborator · 2020-12-01
NOT_YET_RECRUITING
Rehabilitation After Breast CancerNCT03254875 · collaborator · 2017-08-15
COMPLETED
Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer (ImmunoSABR)NCT02735850 · collaborator · 2015-12-01
WITHDRAWN
Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic DiseasesNCT03214263 · collaborator · 2015-05-01
UNKNOWN
Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval TrainingNCT01724567 · collaborator · 2011-09-01
COMPLETED
A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung CancerNCT01188707 · collaborator · 2010-10-01
TERMINATED
Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung CancerNCT00888511 · collaborator · 2009-05-01
COMPLETED
Navelbine And Radiotherapy in Locally Advanced Lung CancerNCT00887783 · collaborator · 2009-05-01
COMPLETED

Drugs studied in this sponsor's trials

3 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Copenhagen University Hospital at Herlev as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
Navelbine1
placebo1
Tarceva1

Sponsor roles

collaborator18
lead sponsor14
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.